Similar articles for PMID: 16459945

Year	Number of Results
1984	1
1996	2
1997	3
1998	1
1999	1
2000	2
2001	5
2002	3
2003	6
2004	5
2005	13
2006	5
2007	5
2008	11
2009	5
2010	9
2011	14
2012	7
2013	5
2014	6
2015	6
2016	2
2017	1
2019	2
2021	4
2022	3
2023	1
2024	0

1

The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.

Reid SC, Teesson M, Sannibale C, Matsuda M, Haber PS. Reid SC, et al. J Stud Alcohol. 2005 Nov;66(6):833-41. doi: 10.15288/jsa.2005.66.833. J Stud Alcohol. 2005. PMID: 16459945 Clinical Trial.

2

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E. Namkoong K, et al. Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41. doi: 10.1093/alcalc/agg038. Alcohol Alcohol. 2003. PMID: 12634260 Clinical Trial.

3

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS. Morley KC, et al. Addiction. 2006 Oct;101(10):1451-62. doi: 10.1111/j.1360-0443.2006.01555.x. Addiction. 2006. PMID: 16968347 Clinical Trial.

4

Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

De Wildt WA, Schippers GM, Van Den Brink W, Potgieter AS, Deckers F, Bets D. De Wildt WA, et al. Alcohol Alcohol. 2002 Jul-Aug;37(4):375-82. doi: 10.1093/alcalc/37.4.375. Alcohol Alcohol. 2002. PMID: 12107041 Clinical Trial.

5

Pharmacological treatment of alcohol dependence: a review of the evidence.

Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Garbutt JC, et al. JAMA. 1999 Apr 14;281(14):1318-25. doi: 10.1001/jama.281.14.1318. JAMA. 1999. PMID: 10208148

6

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group. Anton RF, et al. JAMA. 2006 May 3;295(17):2003-17. doi: 10.1001/jama.295.17.2003. JAMA. 2006. PMID: 16670409 Clinical Trial.

7

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

Feeney GF, Connor JP, Young RM, Tucker J, McPherson A. Feeney GF, et al. Alcohol Alcohol. 2006 May-Jun;41(3):321-7. doi: 10.1093/alcalc/agl007. Epub 2006 Feb 8. Alcohol Alcohol. 2006. PMID: 16467406 Clinical Trial.

8

Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.

Thompson A, Ashcroft DM, Owens L, van Staa TP, Pirmohamed M. Thompson A, et al. PLoS One. 2017 Mar 20;12(3):e0173272. doi: 10.1371/journal.pone.0173272. eCollection 2017. PLoS One. 2017. PMID: 28319159 Free PMC article.

9

Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.

Soyka M, Preuss U, Schuetz C. Soyka M, et al. Drugs R D. 2002;3(1):1-12. doi: 10.2165/00126839-200203010-00001. Drugs R D. 2002. PMID: 11881521 Clinical Trial.

10

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T. Rubio G, et al. Alcohol Alcohol. 2001 Sep-Oct;36(5):419-25. doi: 10.1093/alcalc/36.5.419. Alcohol Alcohol. 2001. PMID: 11524308 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year